Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer
✍ Scribed by Fabi, Alessandra; Merola, Roberta; Ferretti, Gianluigi; Di Benedetto, Anna; Antoniani, Barbara; Ercolani, Cristiana; Nisticò, Cecilia; Papaldo, Paola; Ciccarese, Mariangela; Sperduti, Isabella; Vici, Patrizia; Marino, Mirella; Gori, Stefania; Botti, Claudio; Malaguti, Paola; Cognetti, Francesco; Mottolese, Marcella
- Book ID
- 120188793
- Publisher
- Informa plc
- Year
- 2013
- Tongue
- English
- Weight
- 428 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1465-6566
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a